Home
Ventyx Biosciences

Ventyx Biosciences Market Share Analysis for August 2026

Privacy Policy Updated: April 4, 2022 This Privacy Policy describes the privacy practices of Ventyx Biosciences, Inc. and its subsidiaries (“Ventyx”, “we”, “us” or “our”). Protecting the privacy and security of your personal information is important to Ventyx. This Privacy Policy is designed to help you understand what data Ventyx may collect, how Ventyx uses […]

Health > Biotechnology and Pharmaceuticals

Domainventyxbio.com

Year Founded2018

Employees51 - 200

Annual Revenue--

Ventyx Biosciences

Ventyx Biosciences (including company regionals)

ventyxbio.com

See more website traffic and engagement information

Total visits to Ventyx Biosciences's top domains

Understand Ventyx Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ventyxbio.com--

See more with Sales Intelligence

Avg. visit duration in Ventyx Biosciences's top domains

Analyze Ventyx Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ventyxbio.com--

See more with Sales Intelligence

Avg. pageviews on Ventyx Biosciences's top domains

See how Ventyx Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ventyxbio.com--

See more with Sales Intelligence

Ventyx Biosciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

clinicaltrials.govCompany NameClinicalTrials.govEmployees201 - 500HQUnited States, North Carolina, DurhamAnnual revenue$15M - $25MTotal visits3MHealth > Health - Other

Top technologies used by Ventyx Biosciences

These are the website technologies, by industry, used by Ventyx Biosciences top domains

Widget (3)

Twemoji

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Ventyx Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVentyx Biosciences, Inc. attended event 75th Annual Scientific Session & Expo on Mar 30th '26.On 30 March, at the American College of Cardiology (ACC) 75th Annual Scientific Session & Expo in New Orleans, Louisiana, Phase IIa (NCT06771115) trial results were presented for Ventyx Biosciences' VTX3232 (parunoflast), which was evaluated alone or in combination with semaglutide in patients with obesity.

NewsVentyx Biosciences, Inc. has issues with securities fraud or other unlawful business practices.The investigation concerns whether Ventyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NewsVentyx Biosciences, Inc. launched mid-stage data for lead program VTX3232 on Jun 17th '25.The deal announced after Wednesday's market close follows Ventyx's fall release of mid-stage data for lead program VTX3232, a drug in development for treating inflammation that contributes to cardiovascular disease.